Free Newsletter
SPOTLIGHT: Positive Velcade data fuels stock rise
Free newsletter via e-mail
Tools
Shares of Millennium Pharmaceuticals shot up this morning after the company announced that a late-stage trial of Velcade proved effective against multiple myeloma. Researchers stopped the trial so that all the participants could receive the drug, which is also being developed for non-Hodgkin's lymphoma. Release
More stories about Drug Trials non-Hodgkin's lymphoma Millennium Pharmaceuticals multiple myeloma Velcade lymphoma
Click here to get the FierceBiotech email newsletter for FREE!
Be the first to comment